XML 38 R23.htm IDEA: XBRL DOCUMENT
v3.26.1

INVESTMENTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Investments, All Other Investments [Abstract] |
Schedule of Cash and Financial Assets Measured at Fair Value on a Recurring Basis | The following tables present the Company’s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):
| March 31, 2026
| Cost |  | Unrealized Gains (Losses) |  | Accrued Interest |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Investment Securities
Cash and cash equivalents, excluding money market accounts | $ | 50,961 |  | $ | — |  | $ | — |  | $ | 50,961 |  | $ | 50,961 |  | $ | —
Level 1: |  |  |  |  |  |  |  |  |  |  |
Money market accounts | 20,568 |  | — |  | — |  | 20,568 |  | 20,568 |  | —
Government & agency securities | 45,398 |  | 95 |  | 83 |  | 45,576 |  | — |  | 45,576
| 65,966 |  | 95 |  | 83 |  | 66,144 |  | 20,568 |  | 45,576
Level 2: |  |  |  |  |  |  |  |  |  |  |
Corporate bonds | 51,513 |  | (54) |  | 382 |  | 51,841 |  | — |  | 51,841
Total | $ | 168,440 |  | $ | 41 |  | $ | 465 |  | $ | 168,946 |  | $ | 71,529 |  | $ | 97,417
| December 31, 2025
| Cost |  | Unrealized Gains (Losses |  | Accrued Interest |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Investment Securities
Cash and cash equivalents, excluding money market accounts | $ | 50,187 |  | $ | — |  | $ | — |  | $ | 50,187 |  | $ | 50,187 |  | $ | —
Level 1: |  |  |  |  |  |  |  |  |  |  |
Money market accounts | 39,116 |  | — |  | — |  | 39,116 |  | 39,116 |  | —
Government & agency securities | 23,247 |  | 111 |  | 80 |  | 23,438 |  | — |  | 23,438
| 62,363 |  | 111 |  | 80 |  | 62,554 |  | 39,116 |  | 23,438
Level 2: |  |  |  |  |  |  |  |  |  |  |
Corporate bonds | 53,801 |  | 198 |  | 533 |  | 54,532 |  | — |  | 54,532
Total | $ | 166,351 |  | $ | 309 |  | $ | 613 |  | $ | 167,273 |  | $ | 89,303 |  | $ | 77,970
Summary of Investment Gains | The gains related to the Company’s LifeMD investment for the three months ended March 31, 2026 and 2025 are summarized in the table below (in thousands):
| March 31, 2026 |  | March 31, 2025 |
Net gains recognized during the period on equity securities | $ | — |  |  | $ | 600 |  |
Less: Net gains recognized on equity securities sold | — |  |  | — |  |
Unrealized gains recognized during the reporting period on equity securities still held at the reporting date | $ | — |  |  | $ | 600 |  |

X
- Definition Tabular disclosure of realized and unrealized gain (loss) on investment in security. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(9)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(7)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_GainLossOnInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration